- Home
- EWTX vs AMPX Comparison
EWTX vs AMPX Comparison
Compare EWTX & AMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWTX
- AMPX
- Stock Information
- Founded
- EWTX 2017
- AMPX 2008
- Country
- EWTX United States
- AMPX United States
- Employees
- EWTX N/A
- AMPX N/A
- Industry
- EWTX Biotechnology: Pharmaceutical Preparations
- AMPX Industrial Machinery/Components
- Sector
- EWTX Health Care
- AMPX Miscellaneous
- Exchange
- EWTX Nasdaq
- AMPX Nasdaq
- Market Cap
- EWTX 1.6B
- AMPX 1.8B
- IPO Year
- EWTX 2021
- AMPX N/A
- Fundamental
- Price
- EWTX $21.22
- AMPX $12.61
- Analyst Decision
- EWTX Buy
- AMPX Strong Buy
- Analyst Count
- EWTX 10
- AMPX 7
- Target Price
- EWTX $36.90
- AMPX $13.33
- AVG Volume (30 Days)
- EWTX 1.0M
- AMPX 9.0M
- Earning Date
- EWTX 11-06-2025
- AMPX 11-06-2025
- Dividend Yield
- EWTX N/A
- AMPX N/A
- EPS Growth
- EWTX N/A
- AMPX N/A
- EPS
- EWTX N/A
- AMPX N/A
- Revenue
- EWTX N/A
- AMPX $58,408,000.00
- Revenue This Year
- EWTX N/A
- AMPX $177.55
- Revenue Next Year
- EWTX N/A
- AMPX $171.83
- P/E Ratio
- EWTX N/A
- AMPX N/A
- Revenue Growth
- EWTX N/A
- AMPX 234.14
- 52 Week Low
- EWTX $10.60
- AMPX $1.63
- 52 Week High
- EWTX $35.99
- AMPX $16.03
- Technical
- Relative Strength Index (RSI)
- EWTX 74.48
- AMPX 49.99
- Support Level
- EWTX $16.70
- AMPX $10.62
- Resistance Level
- EWTX $18.26
- AMPX $14.49
- Average True Range (ATR)
- EWTX 1.25
- AMPX 1.33
- MACD
- EWTX 0.39
- AMPX -0.10
- Stochastic Oscillator
- EWTX 93.28
- AMPX 42.24
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.
About AMPX Amprius Technologies Inc.
Amprius Technologies Inc is engaged in the production of silicon anodes for high-energy-density lithium-ion batteries. The company develops, manufactures and markets lithium-ion batteries for mobility applications, including the aviation, electric vehicle (EV) and light electric vehicle (LEV) industries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites.